Cytori Therapeutics Inc. (CYTX) announced that it received a U.S. Patent which covers the company's methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. The patent also covers methods for delivering cell-enriched fat grafts to a patient's breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.
Christopher Calhoun, CEO, said, "The patent covers many significant applications for stem and regenerative cell-enriched fat grafting, allowing us to freely develop future generation therapeutics and pursue solutions for patients with unmet medical needs in tissue damage indications, including breast reconstruction".
For comments and feedback: editorial@rttnews.com